Cystografin
diatrizoate meglumine
- Strength
- 300 mg/mL
- Form
- Injection, Solution
- Class
- Radiographic Contrast Agent
BRACCO DIAGNOSTICS INC
Not stocked by us — reference only
Listed by Guardian Drug Company
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
| Dosage form | Solution |
|---|---|
| Route | Oral, Rectal |
| Drug class | Radiographic Contrast Agent; Radiographic Contrast Agent |
| Approval route | ANDA — approved generic |
| NDC code | 53041-690 |
| FDA application | ANDA214201 |
| Package sizes listed | 2 |
| Marketed since | December 2019 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
diatrizoate meglumine
BRACCO DIAGNOSTICS INC
Not stocked by us — reference only
diatrizoate meglumine
BRACCO DIAGNOSTICS INC
Not stocked by us — reference only
Guardian Drug Company
Not stocked by us — reference only
Camber Pharmaceuticals, Inc.
Not stocked by us — reference only
diatrizoate meglumine and diatrizoate sodium
Bracco Diagnostics Inc
Not stocked by us — reference only
diatrizoate meglumine and diatrizoate sodium
Liebel-Flarsheim Company LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.